<DOC>
	<DOCNO>NCT01304706</DOCNO>
	<brief_summary>This study ass safety utility new inserter administration ILUVIEN subject diabetic macular edema .</brief_summary>
	<brief_title>Fluocinolone Acetonide Diabetic Macular Edema ( FAME ) Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<criteria>1 . Subjects previously participate FAME study subject chronic DME consider insufficiently responsive available therapy . 2 . In judgment Investigator , subject benefit treatment ILUVIEN . 3 . Ability willingness comply treatment follow procedure . 4 . Ability understand sign Informed Consent Form . No expectation subject move area clinical center area cover another clinical center next 12 month . 1 . Pregnant , lactate female female childbearing potential ( unless use reliable contraception , i.e . double barrier , surgical sterilization , oral contraceptive , Norplant , intrauterine device ( IUD ) 2 . Glaucoma , define glaucomatous anatomical change optic disc and/or visual field change screen study eye 3 . Retinal choroidal neovascularization due ocular condition diabetic retinopathy ( e.g. , presumed ocular histoplasmosis , high myopia ( spherical equivalent &gt; 8 diopter ) , macular degeneration ) 4 . Any active viral , fungal bacterial disease cornea conjunctiva history potentially recurrent infection could activate treatment steroid , ( e.g. , ocular herpes simplex virus ) 5 . Known suspected hypersensitivity ingredient investigational product corticosteroid 6 . History uncontrolled IOP elevation steroid use respond topical therapy IOPlowering procedure 7 . History presence disease condition ( malignancy ) investigator 's opinion would preclude study treatment followup 8 . Any lens opacity significantly impair vision , opinion investigator . 9 . Peripheral retinal detachment prospective area insertion 10 . Participation another clinical trial within 12 week screen visit study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>